Mitochondrial one-carbon enzyme MTHFD1L sustains stemness and metastatic progression in breast cancer

Authors:
Preprint
Publisher website
Google Scholar
Abstract
One-carbon (1C) metabolism is frequently upregulated in cancer to support anabolic growth and nucleotide biosynthesis. However, the contribution of mitochondrial 1C metabolism to cancer stemness and metastatic progression remains incompletely understood. Here, we identify methylenetetrahydrofolate dehydrogenase 1-like (MTHFD1L), a mitochondrial 1C metabolic enzyme, as a critical regulator of breast cancer stemness, tumor initiation, and lung metastasis. Genetic depletion of MTHFD1L in triple-negative breast cancer (TNBC) cell lines and patient-derived breast cancer models markedly impaired proliferation, sphere formation, tumorigenicity, and lung colonization. Metabolomic profiling revealed extensive metabolic rewiring following MTHFD1L loss, characterized by accumulation of the purine biosynthetic intermediates SAICAR and AICAR together with perturbations in glycolytic and pentose phosphate pathways. Importantly, suppression of lung metastasis was accompanied by reduced expression of the stemness-associated transcription factor SOX2 and decreased proliferative activity in metastatic lesions. Collectively, our findings establish MTHFD1L as a key metabolic dependency linking mitochondrial 1C metabolism to stem-like properties and metastatic progression in breast cancer, and highlight MTHFD1L as a promising therapeutic target in metastatic TNBC.
Funding Information
  • JSPS KAKENHI (JP23K18237)
  • JSPS KAKENHI (JP24K02304)
  • JSPS KAKENHI (JP25K22575)
  • Japan Agency for Medical Research and Development (21447913)
  • Japan Agency for Medical Research and Development (21446781)
  • Japan Agency for Medical Research and Development (24028177)
  • Japan Agency for Medical Research and Development (24021759)
  • Ministry of Education, Culture, Sports, Science and Technology (JPMXP1323015484)

This publication has 38 references indexed in Scilit: